Clinical Trials Directory

Trials / Completed

CompletedNCT00161486

The Effects of Testosterone on Prostate Tissue (ACYP-1)

The Effects of Testosterone on Prostate Tissue in Normal Men (ACYP-1)

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
13 (actual)
Sponsor
University of Washington · Academic / Other
Sex
Male
Age
35 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to understand the effects of testosterone on the prostate. This knowledge will be used to help in the development of a safe male hormonal contraceptive and may impact the development of androgen replacement therapy in older men.

Detailed description

We will be administering two drugs: Testim (testosterone gel) and Acyline. Acyline is an experimental drug. We want to see their effects on levels of hormones in the blood and prostate. In addition, we will be examining the effects of these drugs on the expression of genes within the prostate. Acyline suppresses LH and FSH, which are hormones made by the pituitary gland, thus blocking the signal from the brain that causes the testes to make testosterone. Therefore, Acyline blocks testosterone production. In preliminary studies, a single injection of Acyline reversibly lowered the FSH, LH and testosterone levels in the blood for approximately 15 days. Prolonged low levels of LH and FSH cause suppression of sperm production in normal men. However, men may experience some side effects from the low levels of testosterone caused by acyline, thus exogenous testosterone is required to sustain normal male androgen and organ effects without suppressing spermatogenesis. This combination of drugs is a promising male contraceptive regimen. In addition, millions of older men are using testosterone replacement to treat male "andropause"; low level testosterone associated with aging. However, the effect of testosterone on the prostate is unknown. Studies examining the effect of testosterone on the prostate are needed.

Conditions

Interventions

TypeNameDescription
DRUGTestosterone gelTestosterone gel 100 mg daily for 4 weeks
DRUGAcylineAcyline 300 μg/kg every two weeks (2 doses) for 4 weeks
DRUGPlacebo acylinePlacebo acyline injections every two weeks (2 doses)
DRUGPlacebo Testosterone gelplacebo testosterone gel daily for 4 weeks

Timeline

Start date
2004-07-01
Primary completion
2004-11-01
Completion
2004-11-01
First posted
2005-09-12
Last updated
2008-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00161486. Inclusion in this directory is not an endorsement.